News
-
-
PRESS RELEASE
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA declares the number of shares and voting rights in their issued capital according to French regulations. Total shares: 97,330,405. Total voting rights: 164,770,927 -
PRESS RELEASE
Games of the Future 2026 Confirms Global Lineup for Astana
Games of the Future 2026 confirms the final lineup of clubs and athletes set to compete at the world's leading phygital sporting event in Astana, featuring elite esports and sporting competition across eight disciplines with over US$4 million in prize money -
PRESS RELEASE
Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
Abivax prices highly oversubscribed $800M public offering of American Depositary Shares, with increased gross proceeds expected to support commercialization efforts and clinical development -
-
-
-
PRESS RELEASE
AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans
AdJane reports first clinical validation of its OMV vaccine platform inducing mucosal immunity in humans. Study demonstrates intranasal OMV-based vaccination's ability to trigger systemic and mucosal immune responses -
-
PRESS RELEASE
ams OSRAM closes the sale of its non‑optical analog/mixed-signal sensor business to Infineon for EUR 570 million in cash
ams OSRAM closes the sale of its non‑optical analog/mixed-signal sensor business to Infineon for EUR 570 million in cash. The divestment allows focused resources on core business and growth opportunities
